Caligor Coghlan Pharma Services, a prominent player in the pharmaceutical services industry, is headquartered in the United States. Founded in 1974, the company has established itself as a leader in providing comprehensive supply chain solutions, clinical trial support, and logistics services tailored for the life sciences sector. With operational regions spanning North America and Europe, Caligor Coghlan is well-positioned to meet the diverse needs of its global clientele. The company’s core offerings include temperature-controlled logistics, clinical trial supply management, and custom packaging solutions, all designed to ensure the integrity and compliance of pharmaceutical products. Notably, Caligor Coghlan has achieved significant milestones, including strategic partnerships that enhance its market position. With a commitment to quality and innovation, Caligor Coghlan Pharma Services continues to set industry standards, making it a trusted partner for pharmaceutical and biotech companies worldwide.
How does Caligor Coghlan Pharma Services's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Caligor Coghlan Pharma Services's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Caligor Coghlan Pharma Services, headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. As a result, there is no information on their commitments to reducing carbon emissions or any initiatives that may be in place to address climate change. Without specific data or targets, it is challenging to assess their environmental impact or commitment to sustainability within the pharmaceutical services industry.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Caligor Coghlan Pharma Services has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
